SCHEMBL25355295

SCHEMBL25355295

CC1CC2(CCN1C(=O)O)OCCc1cc(CC(F)F)sc12

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 20/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25357190 1.00 OPRL1 (0.40) OPRL1
SCHEMBL25356543 0.89 OPRL1 (0.37) OPRL1
SCHEMBL25358166 0.89 OPRL1 (0.36) OPRL1
SCHEMBL31387302 0.88 OPRL1 (0.36) OPRL1
SCHEMBL26059141 0.88 OPRL1 (0.36) OPRL1
SCHEMBL25359569 0.87 OPRL1 (0.35) OPRL1
SCHEMBL25358043 0.86 OPRL1 (0.37) OPRL1
SCHEMBL26042319 0.85 OPRL1 (0.40) OPRL1
SCHEMBL25358272 0.84 OPRL1 (0.35) OPRL1
SCHEMBL25361816 0.84 OPRL1 (0.35) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed